Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate how effective quetiapine versus placebo is when added to an existing therapy, in reducing the symptoms of PTSD.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AstraZeneca
NCT05358067 · Post-traumatic Stress Disorder
NCT07196332 · Post-traumatic Stress Disorder
NCT06096740 · Post Traumatic Stress Disorder, Diminished Pleasure, and more
NCT06002633 · Post-Traumatic Stress Disorder, Alcohol Drinking
NCT06592677 · Post-traumatic Stress Disorder
Research Site
Brisbane, Queensland
Research Site
Adelaide, South Australia
Research Site
Melbourne, Victoria
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions